SINGAPORE - The urgent search for a Covid-19 vaccine should not be seen as a competition, said British pharmaceutical giant GlaxoSmithKline (GSK).
In a press conference for global media outlets hosted online on Wednesday (June 10), the firm noted efforts by multiple players around the world to produce a vaccine amid the mounting death toll and economic disruptions caused by the coronavirus.
Image: There are currently more than 130 candidate vaccines being studied by research groups and pharmaceutical companies.PHOTO: ST FILE
